vs

Side-by-side financial comparison of Axil Brands, Inc. (AXIL) and NVE CORP (NVEC). Click either name above to swap in a different company.

Axil Brands, Inc. is the larger business by last-quarter revenue ($8.1M vs $6.2M, roughly 1.3× NVE CORP). NVE CORP runs the higher net margin — 54.4% vs 8.7%, a 45.7% gap on every dollar of revenue. On growth, NVE CORP posted the faster year-over-year revenue change (22.9% vs 5.2%). Axil Brands, Inc. produced more free cash flow last quarter ($906.4K vs $-4.8M). Over the past eight quarters, Axil Brands, Inc.'s revenue compounded faster (12.1% CAGR vs -6.3%).

Axil Brands, Inc. is a U.S.-headquartered company that designs, manufactures and markets premium hearing protection products, audio enhancement devices and personal audio accessories. Its offerings include custom-fit earplugs, Bluetooth-enabled hearing buds for work, sports and leisure use, serving both consumer and professional segments across global markets.

NVE Corporation develops and manufactures spintronic-based electronic components, including high-performance magnetoresistive sensors, couplers, and signal isolators. Its products are used in industrial automation, automotive systems, medical devices, and IoT applications, serving global original equipment manufacturers and electronic component distributors.

AXIL vs NVEC — Head-to-Head

Bigger by revenue
AXIL
AXIL
1.3× larger
AXIL
$8.1M
$6.2M
NVEC
Growing faster (revenue YoY)
NVEC
NVEC
+17.7% gap
NVEC
22.9%
5.2%
AXIL
Higher net margin
NVEC
NVEC
45.7% more per $
NVEC
54.4%
8.7%
AXIL
More free cash flow
AXIL
AXIL
$5.7M more FCF
AXIL
$906.4K
$-4.8M
NVEC
Faster 2-yr revenue CAGR
AXIL
AXIL
Annualised
AXIL
12.1%
-6.3%
NVEC

Income Statement — Q2 FY2026 vs Q3 FY2026

Metric
AXIL
AXIL
NVEC
NVEC
Revenue
$8.1M
$6.2M
Net Profit
$704.9K
$3.4M
Gross Margin
68.1%
78.6%
Operating Margin
11.1%
60.2%
Net Margin
8.7%
54.4%
Revenue YoY
5.2%
22.9%
Net Profit YoY
11.2%
11.0%
EPS (diluted)
$0.09
$0.70

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXIL
AXIL
NVEC
NVEC
Q4 25
$8.1M
$6.2M
Q3 25
$6.9M
$6.3M
Q2 25
$5.8M
$6.1M
Q1 25
$6.9M
$7.3M
Q4 24
$7.7M
$5.1M
Q3 24
$5.9M
$6.8M
Q2 24
$6.5M
$6.8M
Q1 24
$6.5M
$7.1M
Net Profit
AXIL
AXIL
NVEC
NVEC
Q4 25
$704.9K
$3.4M
Q3 25
$334.3K
$3.3M
Q2 25
$-245.6K
$3.6M
Q1 25
$576.7K
$3.9M
Q4 24
$633.7K
$3.0M
Q3 24
$-109.8K
$4.0M
Q2 24
$49.5K
$4.1M
Q1 24
$781.1K
$3.8M
Gross Margin
AXIL
AXIL
NVEC
NVEC
Q4 25
68.1%
78.6%
Q3 25
67.6%
78.3%
Q2 25
70.0%
80.6%
Q1 25
71.7%
79.2%
Q4 24
71.1%
84.2%
Q3 24
71.0%
86.0%
Q2 24
71.5%
85.6%
Q1 24
71.5%
75.5%
Operating Margin
AXIL
AXIL
NVEC
NVEC
Q4 25
11.1%
60.2%
Q3 25
6.0%
57.6%
Q2 25
0.8%
62.0%
Q1 25
8.4%
58.4%
Q4 24
8.7%
58.5%
Q3 24
-2.4%
65.0%
Q2 24
2.6%
64.7%
Q1 24
-1.6%
57.3%
Net Margin
AXIL
AXIL
NVEC
NVEC
Q4 25
8.7%
54.4%
Q3 25
4.9%
52.2%
Q2 25
-4.3%
58.6%
Q1 25
8.3%
53.5%
Q4 24
8.2%
60.2%
Q3 24
-1.9%
59.6%
Q2 24
0.8%
60.4%
Q1 24
12.1%
53.8%
EPS (diluted)
AXIL
AXIL
NVEC
NVEC
Q4 25
$0.09
$0.70
Q3 25
$0.04
$0.68
Q2 25
$-0.03
$0.74
Q1 25
$0.07
$0.80
Q4 24
$0.08
$0.63
Q3 24
$-0.02
$0.83
Q2 24
$0.11
$0.85
Q1 24
$0.04
$0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXIL
AXIL
NVEC
NVEC
Cash + ST InvestmentsLiquidity on hand
$5.0M
$20.6M
Total DebtLower is stronger
$138.3K
Stockholders' EquityBook value
$11.1M
$58.3M
Total Assets
$16.2M
$60.0M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXIL
AXIL
NVEC
NVEC
Q4 25
$5.0M
$20.6M
Q3 25
$4.1M
$17.7M
Q2 25
$4.8M
$15.8M
Q1 25
$4.7M
$21.7M
Q4 24
$5.2M
$20.4M
Q3 24
$4.1M
$22.9M
Q2 24
$3.3M
$21.7M
Q1 24
$4.9M
$22.2M
Total Debt
AXIL
AXIL
NVEC
NVEC
Q4 25
$138.3K
Q3 25
$139.2K
Q2 25
$140.2K
Q1 25
$141.0K
Q4 24
$143.3K
Q3 24
$144.3K
Q2 24
$146.6K
Q1 24
Stockholders' Equity
AXIL
AXIL
NVEC
NVEC
Q4 25
$11.1M
$58.3M
Q3 25
$10.2M
$59.7M
Q2 25
$9.7M
$61.1M
Q1 25
$9.7M
$62.3M
Q4 24
$8.8M
$63.0M
Q3 24
$7.9M
$64.9M
Q2 24
$7.7M
$64.9M
Q1 24
$8.8M
$65.6M
Total Assets
AXIL
AXIL
NVEC
NVEC
Q4 25
$16.2M
$60.0M
Q3 25
$15.4M
$61.5M
Q2 25
$12.9M
$63.6M
Q1 25
$13.0M
$64.3M
Q4 24
$13.7M
$64.6M
Q3 24
$11.4M
$65.9M
Q2 24
$11.0M
$66.7M
Q1 24
$12.7M
$66.8M
Debt / Equity
AXIL
AXIL
NVEC
NVEC
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.02×
Q3 24
0.02×
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXIL
AXIL
NVEC
NVEC
Operating Cash FlowLast quarter
$934.8K
$4.2M
Free Cash FlowOCF − Capex
$906.4K
$-4.8M
FCF MarginFCF / Revenue
11.1%
-77.0%
Capex IntensityCapex / Revenue
0.3%
144.3%
Cash ConversionOCF / Net Profit
1.33×
1.24×
TTM Free Cash FlowTrailing 4 quarters
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXIL
AXIL
NVEC
NVEC
Q4 25
$934.8K
$4.2M
Q3 25
$-739.2K
$2.8M
Q2 25
$194.4K
$5.2M
Q1 25
$-169.9K
$2.5M
Q4 24
$1.0M
$3.8M
Q3 24
$897.3K
$2.1M
Q2 24
$-336.6K
$5.9M
Q1 24
$-912.8K
$3.1M
Free Cash Flow
AXIL
AXIL
NVEC
NVEC
Q4 25
$906.4K
$-4.8M
Q3 25
$-747.6K
$2.7M
Q2 25
$4.1M
Q1 25
$-258.2K
$-7.5M
Q4 24
$941.1K
$-6.3M
Q3 24
$1.9M
Q2 24
$-394.9K
$4.9M
Q1 24
$-922.1K
FCF Margin
AXIL
AXIL
NVEC
NVEC
Q4 25
11.1%
-77.0%
Q3 25
-10.9%
42.9%
Q2 25
67.7%
Q1 25
-3.7%
-103.7%
Q4 24
12.2%
-124.7%
Q3 24
28.5%
Q2 24
-6.1%
72.8%
Q1 24
-14.3%
Capex Intensity
AXIL
AXIL
NVEC
NVEC
Q4 25
0.3%
144.3%
Q3 25
0.1%
1.1%
Q2 25
17.3%
Q1 25
1.3%
137.9%
Q4 24
0.9%
200.6%
Q3 24
3.1%
Q2 24
0.9%
13.5%
Q1 24
0.1%
0.0%
Cash Conversion
AXIL
AXIL
NVEC
NVEC
Q4 25
1.33×
1.24×
Q3 25
-2.21×
0.84×
Q2 25
1.45×
Q1 25
-0.29×
0.64×
Q4 24
1.59×
1.26×
Q3 24
0.53×
Q2 24
-6.80×
1.43×
Q1 24
-1.17×
0.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXIL
AXIL

Hearing Enhancement And Protection$7.8M95%
Other$378.9K5%

NVEC
NVEC

Segment breakdown not available.

Related Comparisons